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Objective
The receptor tyrosine kinase (RTK) Platelet-Derived
Growth Factor Receptor a (PDGFRa) localizes to the
primary cilium, and expression of the constitutive active
PDGFRa D842V mutant has been linked to gastrointest-
inal tumor formation. We set out to investigate whether
expression of D842V causes loss of primary cilia in cul-
tured cells.
Methods
Plasmids encoding GFP-tagged wild type and D842V
mutant PDGFRa were expressed in hTERT-RPE1 cells.
To promote ciliogenesis, transfected cells were grown
under serum-free conditions for 12 hours and in the
presence of various inhibitors. Cilia numbers of GFP-
positive cells were assessed by immunofluorescence
microscopy with antibodies against cilia markers. In par-
allel, cells were analyzed by western blotting to evaluate
expression level and activity of the tagged receptors.
Results
Cells expressing the D842V mutant contained significantly
fewer cilia than cells expressing wild type PDGFRa. Cilia
numbers of D842V-expressing cells were restored to con-
trol levels upon treatment with the RTK inhibitor crenola-
nib, but not with other RTK inhibitors such as AG1296 or
imatinib. Western blot analysis confirmed that D842V
activity is inhibited by crenolanib, but not by AG1296 and
imatinib. Treatment with inhibitors against AKT, ERK1/2
and HDAC6 failed to restore cilia numbers in D842V-
expressing cells, suggesting that the D842V mutant
induces cilium loss by an alternate pathway.
Conclusions
Our results indicate that the D842V mutant promotes
loss of primary cilia by a mechanism that depends on its
kinase activity, but not on activation of AKT, ERK1/2 or
HDAC6. We are currently investigating the mechanism
by which D842V induces loss of cilia.
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